DoseMe Enhances Web-based User Experience and Capability to Further Scale its Precision Dosing Platform
July 01 2024 - 9:00AM
Business Wire
Sophisticated precision dosing software offers
a superior structured perspective that is clinically intuitive with
equitable access for hospitals and healthcare organizations of any
size
DoseMe, a leading provider of model-informed precision dosing
(MIPD) software, announced today the general availability of its
enhanced web-based platform. These technical improvements
streamline the workflow and offer the same user experience as fully
integrated DoseMeRx customers. This change offers caregivers
improved efficiencies.
DoseMeRx is unique, easy-to-use, decision-support software
already used by clinicians worldwide to support patients' dosing.
The platform leverages clinically validated pharmacokinetic drug
models, patient characteristics, and drug concentrations to guide
dose optimization. The proprietary algorithms have been the
lynchpin to dosing strategies and outcomes in millions of
patients.
"The incredible adoption in the marketplace fuels our ongoing
investment in the product roadmap. This current version further
separates DoseMeRx. The best MIPD platform user experience just got
better,” said Paul Edwards, CEO of DoseMe. "The platform is
designed to be equitable for all organizations, with access to all
embedded resources, as precision dosing is instrumental to the
future of medicine.”
The adoption of precision dosing is on the rise as most
pharmacists and clinicians are switching from trough-based to
area-under-the-curve (AUC), and more specifically, focusing on drug
exposure. DoseMe stands at the forefront of the precision dosing
ecosystem, offering rich dataset models informing personalization
for every patient and overall improves efficiency. The enhanced
platform offers visually engaging and highly interactive
dashboards, alongside in-depth reporting and analytics, delivers an
intelligent and guided user experience throughout all phases of the
dosing process. Release highlights include:
- New User Experience: Designed for practitioners and
pharmacists, DoseMeRx Web platform 2.0 delivers a modern look and
feel with visual dashboards, workflows, and built-in guidance for
personalized patient dosing.
- Data Analytics: Optimal user experience – Clear,
standard data report options as well as intuitive data selection.
Identify and report select patient groups, data elements, and time
periods with ease.
- Patient Simulation: Standalone patient simulation
preview panel now displays more information giving you even better
insight into the patient’s current treatment and response.
- Consolidated code-base: Enables all DoseMeRx drug models
on both the integrated and web-based instances.
Learn more about the new delivery of the industry’s top dosing
platform https://doseme-rx.com/.
About DoseMe
DoseMe combines smart technology with science, leveraging
clinically-validated PK/PD models, patient characteristics, drug
concentrations, and genotype to accurately individualize a dose in
seconds. The platform is HIPAA, ISO & FDA compliant and the
only Bayesian dosing platform to be HITRUST CSF certified. For more
information on successful applications of its products, DoseMeRx
and DoseMe Analytics, visit
https://doseme-rx.com/success-stories.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240701439946/en/
Alison Guzzio aburnsguzzio@gmail.com 484-459-3243